Overall Survival (OS) of palbociclib (P) plus endocrine therapy (ET) versus capecitabine (CAP) in hormonereceptor+/HER2 metastatic breast cancer (MBC) that progressed on aromatase inhibitors (AIs). Final results of the PEARL study.
Palbociclib;Capecitabine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Overall Survival (OS) of palbociclib (P) plus endocrine therapy (ET) versus capecitabine (CAP) in hormonereceptor+/HER2 metastatic breast cancer (MBC) that progressed on aromatase inhibitors (AIs). Final results of the PEARL study. ### Output: Palbociclib;Capecitabine